0 Commentaires
0 Parts
371 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Aflibercept Market Size, Share, Trends & Forecast 2033Executive Summary Aflibercept Market Size and Share Analysis ReportCAGR ValueData Bridge Market Research analyses that the aflibercept market which was USD 8,343.15 million in 2022, and would rocket up to USD 13,911.94 million by 2030, and is expected to undergo a CAGR of 5.40% during the forecast period. This indicates that the market value. “Hospitals” dominates the end user...0 Commentaires 0 Parts 5 Vue 0 Aperçu
-
Alvotech (ALVO) files first known Eylea 8 mg biosimilar application in EuropeAlvotech and Advanz Pharma sent AVT29 to the European Medicines Agency on 14 October 2026 as a line extension to Mynzepli, the Eylea 2 mg biosimilar. Alvotech (ALVO) and its partner Advanz Pharma submitted AVT29 to the European Medicines Agency on 14 October 2026, according to a company release issued the same day. AVT29 is a proposed biosimilar to Eylea 8 mg, the higher-dose form of...0 Commentaires 0 Parts 2KB Vue 0 Aperçu